An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships

被引：3
|
作者：
Wang, Jiangming [1 ]
Sun, Xiaojing [1 ]
Li, Na [1 ]
Sheng, Ruilong [2 ]
Guo, Ruihua [1 ,3 ,4 ]
机构：
[1] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China
[2] Univ Madeira, CQM Cent Quim Madeira, Campus Penteada, P-9000390 Funchal, Portugal
[3] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China
[4] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stora, Shanghai 201306, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2023年 / 30卷 / 25期
基金：
中国国家自然科学基金;
关键词：
Antithrombotic; thrombin inhibitor; structure-activity relationship; pharmacokinetics; PROTEASE-ACTIVATED RECEPTORS; DESIGNING ALLOSTERIC REGULATORS; OPTIMIZING PLATELET INHIBITION; ORALLY BIOAVAILABLE SERIES; FACTOR XA INHIBITORS; BIOLOGICAL EVALUATION; ANTITHROMBOTIC COMPOUNDS; IN-VITRO; PART; SCUTELLAREIN DERIVATIVES;
D O I：
10.2174/0929867329666220906105200
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases. Presently, thrombin inhibitors have gradually gained prominence in clinical practice due to their unique potential, such as dabigatran. Nevertheless, the risk of bleeding is not completely eliminated, and the threats of gastrointestinal bleeding are even increased in some cases. Therefore, developing new oral thrombin inhibitors with low side effects is urgent. In this paper, we summarized recent advances in the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters, guiding the next generation of oral thrombin inhibitors.
引用
收藏
页码：2864 / 2930
页数：67
相关论文
共 50 条
  • [21] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [22] The development of novel telomerase inhibitors: Structure-activity relationships
    Cheng, MK
    Modi, C
    Grindon, CR
    Stevens, MFG
    Laughton, CA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
  • [23] Structure-activity relationships of PDE5 inhibitors
    Eros, D.
    Szantai-Kis, Cs.
    Kiss, R.
    Keri, Gy.
    Hegymegi-Barakonyi, B.
    Koevesdi, I.
    Orfi, L.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (16) : 1570 - 1585
  • [24] Structure-activity relationships of some complex I inhibitors
    Miyoshi, H
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02): : 236 - 244
  • [25] STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS
    FUJITA, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) : 923 - 930
  • [26] Synthesis and structure-activity relationship of potent bicyclic lactam thrombin inhibitors
    Bachand, B
    DiMaio, J
    Siddiqui, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) : 913 - 918
  • [27] Deciphering structure-activity relationships in a series of Tat/TAR inhibitors
    Pascale, Lise
    Lopez Gonzalez, Alejandro
    Di Giorgio, Audrey
    Gaysinski, Marc
    Teixido Closa, Jordi
    Estrada Tejedor, Roger
    Azoulay, Stephane
    Patino, Nadia
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (11): : 2327 - 2338
  • [28] Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D
    Whitesitt, CA
    Simon, RL
    Reel, JK
    Sigmund, SK
    Phillips, ML
    Shadle, JK
    Heinz, LJ
    Koppel, GA
    Hunden, DC
    Lifer, SL
    Berry, D
    Ray, J
    Little, SP
    Liu, XD
    Marshall, WS
    Panetta, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2157 - 2162
  • [29] Structure-activity relationships of transmembrane inhibitors of P-glycoprotein.
    Tarasova, N
    Seth, R
    Michejda, CJ
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6072S - 6072S
  • [30] Divergent Structure-Activity Relationships of Structurally Similar Acetylcholinesterase Inhibitors
    Andersson, C. David
    Forsgren, Nina
    Akfur, Christine
    Allgardsson, Anders
    Berg, Lotta
    Engdahl, Cecilia
    Qian, Weixing
    Ekstrom, Fredrik
    Linusson, Anna
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7615 - 7624
12345